Gavin Maxwell, Ph.D., is Unilever SEAC’s safety science advocacy director and has worked for almost 20 years on developing and applying New Approach Methodologies (NAMs) for Next Generation Risk Assessment (NGRA). Maxwell is an immunologist by training and started his Unilever career working on developing non-animal approaches for Skin Sensitization Risk Assessment. Since 2022, most of his time has been spent accelerating use of NAMs for NGRA externally as industry co-chair for the European Partnership for Alternatives Approaches to Animal Testing (EPAA) and helping to establish the International Collaboration for Cosmetics Safety (ICCS), where he co-leads the Core Acceptance Team.